Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Hematological Oncology|June 21, 2012
Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cellsTamar Tadmor, Rona Fell, Aaron Polliack, et al.
Cancers|July 29, 2023
Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic OptionStefano Molica, Constantine Tam, David Allsup, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2017
The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic LeukemiaNatalia Kreiniz, Ofrat Beyar Katz, Aaron Polliack, et al.
Leukemia & Lymphoma|June 12, 2015
Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the targetFortunato Morabito, Massimo Gentile, John F Seymour, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 17, 2003
Retreatment with rituximab alone induces sustained remission in a patient with follicular lymphoma with multiple extranodal sites of involvement, relapsing soon after primary treatment with fludarabine-rituximabYossi Cohen, Dianna Libster, Nael Da'as, et al.
European Journal of Haematology|July 13, 2004
Rapidly progressive diffuse large B-cell lymphoma with initial clinical presentation mimicking seronegative Wegener's granulomatosisYossi Cohen, Gail Amir, Ginette Schibi, et al.
American Journal of Hematology|January 26, 2011
Hypereosinophilia, JAK2V617F, and Budd-Chiari syndrome: who is responsible for what?Elena Mishchenko, Tamar Tadmor, Elad Schiff, et al.
Leukemia & Lymphoma|October 23, 2002
Large B-cell lymphoma manifesting as an invasive cardiac mass: sustained local remission after combination of methotrexate and rituximabYossi Cohen, Na'el Daas, Diana Libster, et al.
Anticancer Research|June 9, 2016
Acute Renal Failure Associated with Lenalidomide Treatment in Multiple Myeloma: A Rare Occurrence?Natalia Kreiniz, Ali Khateeb, Sharon Gino-Moor, et al.
Leukemia & Lymphoma|April 29, 2009
The late adverse events of rituximab therapy--rare but there!Ron Ram, Isaac Ben-Bassat, Ofer Shpilberg, et al.
Pageof 12